ICAD Inc ICAD:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/18/22 EDT
3.00quote price arrow down-0.12 (-3.85%)
Volume
189,309
52 week range
2.91 - 12.73
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.00
  • 52 Week High12.73
  • 52 Week High Date09/02/21
  • 52 Week Low2.91
  • 52 Week Low Date04/22/22

Key Stats

  • Market Cap75.99M
  • Shares Out25.33M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-58.33

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.00
  • 52 Week High12.73
  • 52 Week High Date09/02/21
  • 52 Week Low2.91
  • 52 Week Low Date04/22/22
  • Market Cap75.99M
  • Shares Out25.33M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-58.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-5.81
  • Fwd P/E (NTM)-6.16
  • EBITDA (TTM)-12.403M
  • ROE (TTM)-28.22%
  • Revenue (TTM)32.27M
  • Gross Margin (TTM)71.96%
  • Net Margin (TTM)-40.24%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ICAD Inc

There is no recent news for this security.

Profile

MORE
iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial...
Timothy Irish
Independent Chairman of the Board
Stacey Stevens
President, Chief Executive Officer, Director
Stephen Sarno
Interim Chief Financial Officer
Jonathan Go
Chief Technology Officer
Address
98 Spit Brook Rd Ste 100
Nashua, NH
03062-5737
United States

Top Peers

SYMBOLLASTCHG%CHG
CTSO
Cytosorbents Corp
2.03+0.23+12.78%
LNSR
LENSAR Inc
6.05+0.01+0.17%
ELMD
Electromed Inc
10.05+0.37+3.82%
SSKN
STRATA Skin Sciences Inc
1.00UNCHUNCH
PDEX
Pro-Dex Inc
17.56-0.15-0.85%